Cover Image

Coasting Versus GnRH Antagonist Salvage for the Prevention of Ovarian Hyperstimulation Syndrome

OBJECTIVE: The purpose of the present study is to compare the use of GnRH antagonist salvage versus coasting for the prevention of OHSS in patients undergoing IVF/ICSI cycles with long GnRH agonist protocol. STUDY DESIGN: Medical records of 91 patients (41 in coasting and 49 in GnRH antagonist group...

Full description

Saved in:

Bibliographic Details
Main Authors:	Cavidan Gülerman (Author), Nafiye Yılmaz (Author), Ayla Sargın Oruç (Author), Nazlı Özkan (Author), Ayten Türkkanı (Author), Esma Sarıkaya (Author), Okan Yenicesu (Author)
Format:	Book
Published:	Medical Network, 2016-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prolonged GnRH suppression period in controlled ovarian hyperstimulation cycles: Impacts on IVF outcomes?
by: Ozlem Gun Eryilmaz, et al.
Published: (2012)

GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology
by: Cota Ana Marcia M, et al.
Published: (2012)

GnRH agonist versus GnRH antagonist in <it>in vitro</it> fertilization and embryo transfer (IVF/ET)
by: Depalo Raffaella, et al.
Published: (2012)

Invitro fertilization outcome in triggering with GnRH agonist, Hcg or combination of GnRH agonist and Hcg
by: Alamtaj Samsami, et al.
Published: (2020)

Meta-analysis of trigger timing in normal responders undergoing GnRH antagonist ovarian hyperstimulation protocol
by: Qijun Xie, et al.
Published: (2024)

Stop GnRH-agonist/GnRH-antagonist protocol: a different insight on ovarian stimulation for IVF
by: Raoul Orvieto
Published: (2023)

The effect of luteinizing hormone changes in GnRH antagonist protocol on the outcome of controlled ovarian hyperstimulation and embryo transfer
by: Jing-Shuang Zhou, et al.
Published: (2023)

Early-cleavage is a reliable predictor for embryo implantation in the GnRH agonist protocols but not in the GnRH antagonist protocols
by: Hwu Yuh-Ming, et al.
Published: (2009)

Comparisons of Different Dosages of Gonadotropin-Releasing Hormone (GnRH) Antagonist, Short-acting Form and Single, Half-dose, Long-acting Form of GnRH Agonist During Controlled Ovarian Hyperstimulation and in vitro Fertilization
by: Yao-Yuan Hsieh, et al.
Published: (2008)

GnRH Antagonist/Letrozole Versus Microdose GnRH Agonist Flare Protocol in Poor Responders Undergoing In Vitro Fertilization
by: Robab Davar, et al.
Published: (2010)

Pregnancy outcomes in PCOS patients undergoing IVF with long GnRH agonist protocol versus flexible GnRH antagonist
by: Nayereh Khadem Ghaebi, et al.
Published: (2018)

A prospective study of GnRH long agonist versus flexible GnRH antagonist protocol in PCOS: Indian experience
by: Harpreet Kaur, et al.
Published: (2012)

Cocktail treatment by GnRH-antagonist, letrozole, and mifepristone for the prevention of ovarian hyperstimulation syndrome: a prospective randomized trial
by: Qianrong Qi, et al.
Published: (2023)

A cumulative strategy of GnRH agonist, clomiphene citrate, and GnRH antagonist in a patient with recurrent endometriosis and repeated aspiration
by: Su-Long Lee, et al.
Published: (2011)

GnRH agonist trigger versus hCG trigger in GnRH antagonist in IVF/ICSI cycles: A review article
by: Ashraf Alyasin, et al.
Published: (2016)

Low-dose GnRH antagonist protocol is as effective as the long GnRH agonist protocol in unselected patients undergoing in vitro fertilization and embryo transfer
by: Shang-Yu Huang, et al.
Published: (2011)

Pregnancy outcome of "delayed start" GnRH antagonist protocol versus GnRH antagonist protocol in poor responders: A clinical trial study
by: Abbas Aflatoonian, et al.
Published: (2017)

Comparison of clinical effects between early follicular prolonged GnRH agonist protocol and GnRH antagonist protocol in 3310 cycles: a retrospective study
by: Juan Gui, et al.
Published: (2022)

Role of gonadotropin-releasing hormone (GnRH) in ovarian cancer
by: Emons Günter, et al.
Published: (2003)

Clinical development of the GnRH agonist leuprolide acetate depot
by: Kristof Chwalisz, M.D., Ph.D
Published: (2023)

Suppression of puberty with GnRH analogues in adolescents with Gender Dysphoria
by: Julita Poleszak, et al.
Published: (2019)

Suppression of puberty with GnRH analogues in adolescents with Gender Dysphoria
by: Julita Poleszak, et al.
Published: (2019)

Dienogest in conjunction with GnRH-a for postoperative management of endometriosis
by: Ying Ma, et al.
Published: (2024)

Investigation of the GnRH antagonist degarelix isomerization in biological matrices
by: Lucia Ferrazzano, et al.
Published: (2023)

The Cellular Localization of GnRH and LHR in Aged Female Mice
by: Young-Jong Kim, et al.
Published: (2018)

Comparison of GnRH-a Prolonged Protocol and Short GnRH-a Long Protocol in Patients with Thin Endometrium for Assisted Reproduction: A Retrospective Cohort Study
by: Song J, et al.
Published: (2020)

Comparison of the treatment efficacies of HIFU, HIFU combined with GnRH-a, and HIFU combined with GnRH-a and LNG-IUS for adenomyosis: A systematic review and meta-analysis
by: Altangerel Otgontuya, et al.
Published: (2023)

Add-Back and Combined Regulation in GnRH-a Treatment of Endometriosis
by: Huimin Tang, et al.
Published: (2023)

Comparison of the efficacy of dienogest and GnRH-a after endometriosis surgery
by: Mingjun Tang, et al.
Published: (2023)

Advances in clinical applications of kisspeptin-GnRH pathway in female reproduction
by: Kai-Lun Hu, et al.
Published: (2022)

Polyacrylate-GnRH Peptide Conjugate as an Oral Contraceptive Vaccine Candidate
by: Mohammad O. Faruck, et al.
Published: (2021)

Expression of Concern: Laparoscopic ovarian drilling versus GnRH antagonist combined with cabergoline as a prophylaxis against the re-development of ovarian hyperstimulation syndrome
Published: (2024)

Incidence and severity of ovarian hyperstimulation syndrome (OHSS) in high responders after gonadotropin-releasing hormone (GnRH) agonist trigger in "freeze-all" approach
by: M. Fernández-Sánchez, et al.
Published: (2023)

Observational Study to Assess the Therapeutic Value of Four Ovarian Hyperstimulation Protocols in IVF after Pituitary Suppression with GnRH Antagonists in Normally Responding Women
by: Monzó Ana, et al.
Published: (2011)

Evaluation of GnRH antagonist pretreatment before ovarian stimulation in a GnRH antagonist protocol in normal ovulatory women undergoing IVF/ICSI: a randomized controlled trial
by: Yisheng Zhang, et al.
Published: (2021)

Safety profiles of offspring born from early-follicular long-acting GnRH agonist protocol and daily mid-luteal GnRH agonist protocol: a retrospective study
by: Linqing Du, et al.
Published: (2024)

Utilização da contagem de folículos antrais para predição do padrão de resposta em ciclos de hiperestimulação controlada com antagonista de GnRH Use of antral follicle count to predict the response pattern in controlled ovarian hyperstimulation cycles with GnRH antagonist
by: Maria do Carmo Borges de Souza, et al.
Published: (2008)

Effect of GnRH agonist alone or combined with different low-dose hCG on cumulative live birth rate for high responders in GnRH antagonist cycles: a retrospective study
by: Yuxia He, et al.
Published: (2022)

Gonadotropin-releasing hormone (GnRH)-I and GnRH-II induce cell growth inhibition in human endometrial cancer cells: Involvement of integrin beta3 and focal adhesion kinase
by: MacCalman Colin D, et al.
Published: (2009)

Impact of GnRH ovarian stimulation protocols on intracytoplasmic sperm injection outcomes
by: Silva Joaquina, et al.
Published: (2009)